T Regulatory Cells and Immune Activation in Mycobacterium tuberculosis Infection and the Effect of Preventive Therapy

Scandinavian Journal of Immunology

Volumn 73, Issue 3, 2011, Pages 234-242

  Wergeland, I ^a   Amus, J ^b   Dyrhol Riise, A M ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 7 RECEPTOR; ISONIAZID; RIFAMPICIN; TRANSCRIPTION FACTOR FOXP3; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LATENT TUBERCULOSIS; MALE; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; LATENT TUBERCULOSIS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 79551676026     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02496.x     Document Type: Article

References (27)

1. WHO Global Report on TB Control. 2009
2. Rodrigues DS, Medeiros EA, Weckx LY, Bonnez W, Salomao R, Kallas EG. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Clin Exp Immunol 2002;128:149-54.
3. Hertoghe T, Wajja A, Ntambi L et al. T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol 2000;122:350-7.
4. Belkaid Y, Tarbell K. Regulatory T-cells in the control of host-microorganism interactions. Annu Rev Immunol 2009;27:551-89.
5. Wing K, Sakaguchi S. Regulatory T-cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010;11:7-13.
6. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat Immunol 2003;4:330-6.
7. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM. Human CD4+ regulatory T-cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 2007;1-2:41-52.
8. Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006;7:1701-11.
9. Klein S, Kretz CC, Krammer PH, Kuhn A. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T cell populations in human peripheral blood. J Invest Dermatol 2010;130:492-9.
10. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T-cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006;7:803-10.
11. Hougardy JM, Place S, Hildebrand M et al. Regulatory T-cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med 2007;4:409-16.
12. Marin ND, París SC, Vélez VM, Rojas CA, Rojas M, García LF. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb) 2010;90:252-61.
13. He XY, Xiao L, Chen HB et al. T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients. Eur J Clin Microbiol Infect Dis 2010;29:643-50.
14. Yamazaki S, Steinman RM. Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T-cells. J Dermatol Sci 2009;54:69-75.
15. Henderson RA, Watkins SC, Flynn JL. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997;2:635-43.
16. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
17. Lichtner M, Rossi R, Mengoni F et al. Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response. Clin Exp Immunol 2006;143:329-37.
18. Pai M, Zwerling A, Menzies D. Systematic review: T cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;3:177-84.
19. Winje BA, Mannsåker T, Heldal E, Dahle UR. Forebygging og kontroll av tuberkulose, en veileder (Norwegian) [Guidelines for prevention and control of tuberculosis] 7, Oslo: Nasjonalt Folkehelseinstitutt, 2002.
20. Dyrhol-Riise AM, Gran G, Wenztel-Larsen T, Blomberg B, Gill HC, Morkve O. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 2010;1:57.
21. Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB. Regulatory T-cells modulate Th17 responses in patients with positive tuberculin skin test results. J Infect Dis 2010;1:20-31.
22. Burl S, Hill PC, Jeffries DJ et al. FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol 2007;149:117-22.
23. Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM. FOXP3 expressing CD127lo CD4+ T-cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection. J Leukoc Biol 2008;83:254-62.
24. Ribeiro-Rodrigues R, Resende CT, Rojas R et al. A role for CD4+CD25+ T-cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 2006;144:25-34.
25. Green AM, Mattila JT, Bigbee CL, Bongers KS, Lin PL, Flynn JL. CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. J Infect Dis 2010;4:533-41.
26. Hirsch CS, Toossi Z, Vanham G et al. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis 1999;179:945-53.
27. Chang KC, Leung CC. Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax 2010;65:271-6.